La recherche de l’HPV en dépistage : les modalités pratiques

作者: H. Sevestre , J. -C. Boulanger

DOI: 10.1007/2-287-28699-3_8

关键词:

摘要: L’idee d’integrer le test HPV dans depistage du cancer col est, fait de sa grande sensibilite, une innovation tres seduisante. Son application pose nombreux problemes en raison la frequence portage des a haut risque population generale. Le choix d’inclure ou non ce strategie ne pourra etre qu’au vu resultat d’etudes cout-efficacite realisees les conditions habituelles France.

参考文章(36)
Eduardo L. Franco, Statistical issues in human papillomavirus testing and screening. Clinics in Laboratory Medicine. ,vol. 20, pp. 345- 367 ,(2000) , 10.1016/S0272-2712(18)30065-9
J. Cuzick, Time to consider HPV testing in cervical screening Annals of Oncology. ,vol. 12, pp. 1511- 1514 ,(2001) , 10.1023/A:1013117823929
Michael T. Fahey, Les Irwig, Petra Macaskill, Meta-analysis of Pap Test Accuracy American Journal of Epidemiology. ,vol. 141, pp. 680- 689 ,(1995) , 10.1093/OXFORDJOURNALS.AJE.A117485
Mark Schiffman, Diane Solomon, None, Findings to date from the ASCUS-LSIL Triage Study (ALTS). Archives of Pathology & Laboratory Medicine. ,vol. 127, pp. 946- 949 ,(2003) , 10.1043/1543-2165(2003)127<946:FTDFTA>2.0.CO;2
Achim Schneider, Heike Hoyer, Beatrix Lotz, Sabine Leistritza, Rosemarie Kühne-Heid, Ingo Nindl, Bernhard Müller, Johannes Haerting, Matthias Dürst, Screening for high‐grade cervical intra‐epithelial neoplasia and cancer by testing for high‐risk HPV, routine cytology or colposcopy International Journal of Cancer. ,vol. 89, pp. 529- 534 ,(2000) , 10.1002/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G
A FERENCZY, M GELFAND, E FRANCO, N MANSOUR, Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstetrics & Gynecology. ,vol. 90, pp. 7- 11 ,(1997) , 10.1016/S0029-7844(97)00217-2
Jean-Paul Bory, Jo�l Cucherousset, Marianne Lorenzato, Ren� Gabriel, Christian Quereux, Philippe Birembaut, Christine Clavel, Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. International Journal of Cancer. ,vol. 102, pp. 519- 525 ,(2002) , 10.1002/IJC.10735
Albertus T. Hesselink, Adriaan J. C. van den Brule, Antoinette A. T. P. Brink, Johannes Berkhof, Folkert J. van Kemenade, René H. M. Verheijen, Peter J. F. Snijders, Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer. ,vol. 102, pp. 11- 18 ,(2003) , 10.1002/CNCR.11904
Attila T Lorincz, Philip E Castle, Mark E Sherman, David R Scott, Andrew G Glass, Sholom Wacholder, Brenda B Rush, Patti E Gravitt, John E Schussler, Mark Schiffman, Viral load of human papillomavirus and risk of CIN3 or cervical cancer. The Lancet. ,vol. 360, pp. 228- 229 ,(2002) , 10.1016/S0140-6736(02)09463-1
Philip E Castle, Diane Solomon, Allan Hildesheim, Rolando Herrero, M Concepcion Bratti, Mark E Sherman, Ana Cecilia Rodriguez, Mario Alfaro, Martha L Hutchinson, S Terence Dunn, Jane Kuypers, Mark Schiffman, None, Stability of archived liquid-based cervical cytologic specimens†‡ Cancer. ,vol. 99, pp. 89- 96 ,(2003) , 10.1002/CNCR.11058